title: Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia.
abstract: Nearly all mutations in the presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid beta precursor protein (APP) genes lead to early-onset Alzheimer disease (EOAD, onset age at or before 65 years). In order to assess the genetic contribution of these genes in a series of Colombian AD cases, we performed a systematic mutation analysis in 11 autosomal dominant, 23 familial, and 42 sporadic AD patients (34% with age of onset < or = 65 years). No APP missense mutations were identified. In three autosomal dominant cases (27.2%), two different PSEN1 missense mutations were identified. Both PSEN1 mutations are missense mutations that occurred in early-onset autosomal AD cases: an I143T mutation in one case (onset age 30 years) and an E280A mutation in two other cases (onset ages 35 and 42 years). In addition, a novel PSEN1 V94M mutation was present in one early-onset AD case without known family history (onset age 53 years) and absent in 53 controls. The E318G polymorphism was present in five AD cases and absent in controls. In PSEN2, two different silent mutations were detected, including one not reported elsewhere (P129). The majority of the Colombian AD cases, predominantly late-onset, were negative for PSEN and APP mutations.
authors.affiliation: Neuro-Sciences Group, Instituto Nacional de Salud, Bogotá, Colombia.
authors.forename: D
authors.initials: D
authors.lastname: Arango
authors.forename: M
authors.initials: M
authors.lastname: Cruts
authors.forename: O
authors.initials: O
authors.lastname: Torres
authors.forename: H
authors.initials: H
authors.lastname: Backhovens
authors.forename: M L
authors.initials: ML
authors.lastname: Serrano
authors.forename: E
authors.initials: E
authors.lastname: Villareal
authors.forename: P
authors.initials: P
authors.lastname: Montañes
authors.forename: D
authors.initials: D
authors.lastname: Matallana
authors.forename: C
authors.initials: C
authors.lastname: Cano
authors.forename: C
authors.initials: C
authors.lastname: Van Broeckhoven
authors.forename: M
authors.initials: M
authors.lastname: Jacquier
mesh_terms: D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000453:epidemiology / Q000235:genetics*; D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D016564:Amyloid beta-Protein Precursor / Q000235:genetics; D001483:Base Sequence; D003105:Colombia / Q000453:epidemiology; D004247:DNA / Q000737:chemistry / Q000235:genetics; D004252:DNA Mutational Analysis; D005260:Female; D005787:Gene Frequency; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000235:genetics; D008875:Middle Aged; D009154:Mutation; D017354:Point Mutation; D012150:Polymorphism, Restriction Fragment Length; D018807:Polymorphism, Single-Stranded Conformational; D053764:Presenilin-1; D053766:Presenilin-2; D011506:Proteins / Q000235:genetics*
chemical_list: D016564:Amyloid beta-Protein Precursor; D008565:Membrane Proteins; C508853:PSEN1 protein, human; C508861:PSEN2 protein, human; D053764:Presenilin-1; D053766:Presenilin-2; D011506:Proteins; D004247:DNA